ADA-话题@MedSci

#ADA#

386篇内容 | 2764人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1264483, encodeId=2ead1264483c6, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=FDA接受审查勃林格抗凝血剂Pradaxa sNDA, objectType=article, longId=23542, objectId=75d92354259, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=75d92354259, replyNumber=0, likeNumber=75, createdTime=2013-09-01, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=75d92354259, moduleTitle=FDA接受审查勃林格抗凝血剂Pradaxa sNDA, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=75d92354259)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264482, encodeId=155f12644825c, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=ADA 2013：甘精胰岛素不增加糖尿病患者癌症风险, objectType=article, longId=22374, objectId=13c2223e4e7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=13c2223e4e7, replyNumber=0, likeNumber=95, createdTime=2013-08-01, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=13c2223e4e7, moduleTitle=ADA 2013：甘精胰岛素不增加糖尿病患者癌症风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=13c2223e4e7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264481, encodeId=e80a1264481ff, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=ADA 2013：周智广：中国自身免疫性糖尿病数量居全球首位, objectType=article, longId=22144, objectId=1efc2214436, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1efc2214436, replyNumber=0, likeNumber=74, createdTime=2013-07-28, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1efc2214436, moduleTitle=ADA 2013：周智广：中国自身免疫性糖尿病数量居全球首位, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1efc2214436)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264480, encodeId=efca1264480c2, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=解读LADA China研究——中国成人自身免疫糖尿病的首项全国性多中心研究, objectType=article, longId=22143, objectId=763e2214388, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=763e2214388, replyNumber=0, likeNumber=87, createdTime=2013-07-28, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=763e2214388, moduleTitle=解读LADA China研究——中国成人自身免疫糖尿病的首项全国性多中心研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=763e2214388)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264479, encodeId=3b9512644e9e0, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=CHMP建议批准赛诺菲单抗药物Lemtrada用于活动性复发缓解型多发性硬化症(RRMS)治疗, objectType=article, longId=20871, objectId=bd2c208e12b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bd2c208e12b, replyNumber=0, likeNumber=68, createdTime=2013-07-05, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bd2c208e12b, moduleTitle=CHMP建议批准赛诺菲单抗药物Lemtrada用于活动性复发缓解型多发性硬化症(RRMS)治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bd2c208e12b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264478, encodeId=b0f412644e888, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=ADA 2013：许樟荣发现中国2型糖尿病合并高尿酸血症的临床特点, objectType=article, longId=20762, objectId=fcbf20e62e2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fcbf20e62e2, replyNumber=0, likeNumber=74, createdTime=2013-07-03, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fcbf20e62e2, moduleTitle=ADA 2013：许樟荣发现中国2型糖尿病合并高尿酸血症的临床特点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fcbf20e62e2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264477, encodeId=7fd112644e7c3, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=ADA 2013：20年来中国2型糖尿病住院患者的死亡原因分析, objectType=article, longId=20761, objectId=d6f720e61ab, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d6f720e61ab, replyNumber=0, likeNumber=56, createdTime=2013-07-03, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d6f720e61ab, moduleTitle=ADA 2013：20年来中国2型糖尿病住院患者的死亡原因分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d6f720e61ab)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264476, encodeId=827112644e6a1, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=ADA 2013：达格列净（Dapagliflozin ）单药治疗未曾用药的T2DM安全有效, objectType=article, longId=20758, objectId=adc720e580f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=adc720e580f, replyNumber=0, likeNumber=75, createdTime=2013-07-03, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=adc720e580f, moduleTitle=ADA 2013：达格列净（Dapagliflozin ）单药治疗未曾用药的T2DM安全有效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=adc720e580f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264475, encodeId=5bc112644e577, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=ADA 2013：纪立农认为ORBIT研究示中国T2DM患者胰岛素治疗不及时, objectType=article, longId=20755, objectId=006d20e5505, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=006d20e5505, replyNumber=0, likeNumber=77, createdTime=2013-07-03, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=006d20e5505, moduleTitle=ADA 2013：纪立农认为ORBIT研究示中国T2DM患者胰岛素治疗不及时, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=006d20e5505)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264474, encodeId=cb9112644e4c3, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=ADA 2013：许樟荣教授认为中国近半非创伤性截肢由糖尿病足所致, objectType=article, longId=20754, objectId=25df20e54dc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=25df20e54dc, replyNumber=0, likeNumber=80, createdTime=2013-07-03, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=25df20e54dc, moduleTitle=ADA 2013：许樟荣教授认为中国近半非创伤性截肢由糖尿病足所致, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=25df20e54dc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264473, encodeId=a52412644e32f, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=ADA 2013：中国糖尿病和IGT患者的卒中风险高（大庆研究）, objectType=article, longId=20753, objectId=aa4e20e5385, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aa4e20e5385, replyNumber=0, likeNumber=58, createdTime=2013-07-03, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aa4e20e5385, moduleTitle=ADA 2013：中国糖尿病和IGT患者的卒中风险高（大庆研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aa4e20e5385)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264470, encodeId=03f612644e0fd, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=ADA 2013：2型糖尿病患者强化生活方式干预无心血管获益（Look AHEAD研究）, objectType=article, longId=20746, objectId=bba620e4654, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bba620e4654, replyNumber=0, likeNumber=69, createdTime=2013-07-03, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bba620e4654, moduleTitle=ADA 2013：2型糖尿病患者强化生活方式干预无心血管获益（Look AHEAD研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bba620e4654)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264471, encodeId=ce3f12644e151, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=ADA 2013：中国原创性糖尿病相关临床研究成果发布, objectType=article, longId=20747, objectId=10eb20e4792, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=10eb20e4792, replyNumber=0, likeNumber=76, createdTime=2013-07-03, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=10eb20e4792, moduleTitle=ADA 2013：中国原创性糖尿病相关临床研究成果发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=10eb20e4792)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264472, encodeId=1a4c12644e22f, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=ADA 2013：减重手术在T2DM治疗中的地位, objectType=article, longId=20748, objectId=823920e487c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=823920e487c, replyNumber=0, likeNumber=75, createdTime=2013-07-03, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=823920e487c, moduleTitle=ADA 2013：减重手术在T2DM治疗中的地位, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=823920e487c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264468, encodeId=04ec126446877, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=ADA 2013：强化降糖治疗留下的疑问, objectType=article, longId=20741, objectId=6afd20e4179, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6afd20e4179, replyNumber=0, likeNumber=74, createdTime=2013-07-03, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6afd20e4179, moduleTitle=ADA 2013：强化降糖治疗留下的疑问, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6afd20e4179)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264469, encodeId=b2fb126446915, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=ADA 2013：ORIGIN试验最终癌症转归数据公布基础胰岛素无关癌症风险, objectType=article, longId=20742, objectId=ef1a20e42c0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ef1a20e42c0, replyNumber=0, likeNumber=51, createdTime=2013-07-03, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ef1a20e42c0, moduleTitle=ADA 2013：ORIGIN试验最终癌症转归数据公布基础胰岛素无关癌症风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ef1a20e42c0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264467, encodeId=3ef7126446e5d, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=ADA2013：阿格列汀与二甲双胍联用治疗糖尿病效果好, objectType=article, longId=20710, objectId=ca3a20e10cc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ca3a20e10cc, replyNumber=0, likeNumber=73, createdTime=2013-07-03, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ca3a20e10cc, moduleTitle=ADA2013：阿格列汀与二甲双胍联用治疗糖尿病效果好, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ca3a20e10cc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264466, encodeId=062d1264466ad, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=ADA：两药联用可增加糖尿病疗效, objectType=article, longId=20675, objectId=25d1206e50c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=25d1206e50c, replyNumber=0, likeNumber=89, createdTime=2013-07-03, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=25d1206e50c, moduleTitle=ADA：两药联用可增加糖尿病疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=25d1206e50c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264464, encodeId=313f126446493, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=ADA：长效基础胰岛素制剂夜间低血糖发生率低, objectType=article, longId=20580, objectId=943520580a2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=943520580a2, replyNumber=0, likeNumber=69, createdTime=2013-06-29, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=943520580a2, moduleTitle=ADA：长效基础胰岛素制剂夜间低血糖发生率低, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=943520580a2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1264465, encodeId=5bb91264465df, content=<a href='/topic/show?id=150f19229c' target=_blank style='color:#2F92EE;'>#ADA#</a>, objectTitle=ADA:新诊断2型糖尿病患者宜初始接受三联治疗, objectType=article, longId=20581, objectId=9c34205812e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9c34205812e, replyNumber=0, likeNumber=75, createdTime=2013-06-29, rootId=0, userName=般若傻瓜, userId=ad9f79, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9c34205812e, moduleTitle=ADA:新诊断2型糖尿病患者宜初始接受三联治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9c34205812e)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

ADA

2020-05-29

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

FDA接受审查勃林格抗凝血剂Pradaxa sNDA

2013-09-01

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

ADA 2013：甘精胰岛素不增加糖尿病患者癌症风险

2013-08-01

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

ADA 2013：周智广：中国自身免疫性糖尿病数量居全球首位

2013-07-28

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

解读LADA China研究——中国成人自身免疫糖尿病的首项全国性多中心研究

2013-07-28

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

CHMP建议批准赛诺菲单抗药物Lemtrada用于活动性复发缓解型多发性硬化症(RRMS)治疗

2013-07-05

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

ADA 2013：许樟荣发现中国2型糖尿病合并高尿酸血症的临床特点

2013-07-03

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

ADA 2013：20年来中国2型糖尿病住院患者的死亡原因分析

2013-07-03

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

ADA 2013：达格列净（Dapagliflozin ）单药治疗未曾用药的T2DM安全有效

2013-07-03

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

ADA 2013：纪立农认为ORBIT研究示中国T2DM患者胰岛素治疗不及时

2013-07-03

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

ADA 2013：许樟荣教授认为中国近半非创伤性截肢由糖尿病足所致

2013-07-03

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

ADA 2013：中国糖尿病和IGT患者的卒中风险高（大庆研究）

2013-07-03

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

ADA 2013：2型糖尿病患者强化生活方式干预无心血管获益（Look AHEAD研究）

2013-07-03

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

ADA 2013：中国原创性糖尿病相关临床研究成果发布

2013-07-03

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

ADA 2013：减重手术在T2DM治疗中的地位

2013-07-03

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

ADA 2013：强化降糖治疗留下的疑问

2013-07-03

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

ADA 2013：ORIGIN试验最终癌症转归数据公布基础胰岛素无关癌症风险

2013-07-03

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

ADA2013：阿格列汀与二甲双胍联用治疗糖尿病效果好

2013-07-03

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

ADA：两药联用可增加糖尿病疗效

2013-07-03

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

ADA：长效基础胰岛素制剂夜间低血糖发生率低

2013-06-29

般若傻瓜 (审核中...)

前往app查看评论内容

#ADA#

ADA:新诊断2型糖尿病患者宜初始接受三联治疗

2013-06-29

科室
- - 订阅+
  - 更多科室
工具
服务